Skip to main content
. 2021 Apr 30;9:665161. doi: 10.3389/fcell.2021.665161

FIGURE 5.

FIGURE 5

Relationship between risk score and chemotherapeutic regimes. (A) Relationship of risk score and chemotherapy sensitivity. (B) K-M curves for the risk signature in patients receiving FOLFIRINOX. (C) K-M curves for the risk signature in patients receiving gemcitabine monotherapy.